Therefore, we combined the CR with AV in a specific nano-platform tackling cancer cells and further experiments were performed to verify by which mechanism CCR2 antagonism inhibited A549 cell proliferation in vitro, and we founded that this strategy is depended on ROS-mediated early apoptosis. This evidence concerns the gene CCR2 and cancer.